Skip to Main Content

Advertisement intended for health care professionals

Skip Nav Destination

First Edition

Research Article May 29 2025
BCLAF1 restrains stress responses in hematopoietic stem cells to support expansion and repopulation
Letter May 28 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
Research Article May 28 2025
Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR
Research Article May 23 2025
Inaccuracies of Venous Thromboembolism Risk Assessment and Prevention Practices Among Medically Ill Patients
Research Article May 22 2025
A Revised Prognostic Model for Patients with Acute Myeloid Leukemia and First Relapse
Research Article May 22 2025
Impact of SARS-CoV-2 infection on bispecific antibody treatment in patients with B-cell lymphoproliferative disorders
Research Article May 22 2025
The SAMD1 transcription factor coordinates hematopoietic lineage differentiation and H3K4 methylation status
Research Article May 22 2025
PRIDE-FTG Advances Academic Careers of Underrepresented Early-Stage Investigators Performing Blood Disorders Research
Research Article May 22 2025
Circulating Tumor DNA Determinants of Response and Outcome in Relapsed/Refractory Mantle Cell Lymphoma
Research Article May 22 2025
Single-cell sequencing on PBMCs from HA & HB patients with inhibitors reveals different immune responses to FVIII & FIX
Letter May 22 2025
RAS Mutation Identifies a Poor Prognostic Molecular Subtype of Therapy-Related Myeloid Neoplasm
Letter May 22 2025
Molecular profiling of primary renal diffuse large B-cell lymphoma unravels a proclivity for immune-privileged tropism
Research Article May 16 2025
Inequalities in CAR T-Cell Therapy Access for US Patients with Relapsed/Refractory DLBCL: A SEER-Medicare Data Analysis
Letter May 14 2025
Drug development for leukemia: comprehensive analysis of clinical trials from first report to drug approval
Research Article May 14 2025
Extramedullary Myeloma is Genomically Complex and Characterized by Near-Universal MAPK Pathway Alterations
Reply May 14 2025
Response to "It might not be whether you get knocked down, but whether you..."
Letter May 14 2025
SGLT2i-associated erythrocytosis: Closing the evidence gap
Research Article May 12 2025
Real-World Survival Outcomes in First-Line Ibrutinib-Treated Patients with High-Risk CLL/SLL
Letter May 12 2025
Fatal Recurrence of IEC-HS Following Autologous Stem Cell Boost in Patients Receiving BCMA CAR-T Cell Therapy
Research Article May 12 2025
Global Survey on Practice Changes and Barriers to the Use of Direct Oral Anticoagulants in Children
Research Article May 12 2025
The CLUE Post-Surgery VTE Risk Instrument for Abdominal and Pelvic Surgery: Validation of Patient Risk Factor Component
Review Article May 12 2025
Advancements in Complement Inhibition for PNH and Primary Complement Mediated Thrombotic Microangiopathy
Research Article May 9 2025
HCAR2 is a novel receptor for heme
Letter May 9 2025
Molecular profiling of primary renal Marginal Zone Lymphoma reveals overlapping features with extranodal Marginal Zone Lymphoma
Letter May 9 2025
Conflating polycythemia vera with essential thrombocytosis
Research Article May 7 2025
Zanubrutinib is well tolerated and effective in CLL/SLL patients intolerant of ibrutinib/acalabrutinib: Updated results
Research Article May 7 2025
Outcomes of Brexucabtagene Autoleucel in Relapsed/Refractory Acute Lymphoblastic Leukemia Patients with CNS Involvement.
Research Article May 7 2025
Pivotal Results of SELECT-MDS-1 Phase 3 Study of Tamibarotene with Azacitidine in Newly Diagnosed Higher-Risk MDS
Research Article May 7 2025
Asciminib remained superior vs bosutinib in late-line CML-CP after nearly 4 years of follow-up in ASCEMBL
Letter May 7 2025
Intrathecal chemotherapy for ciltacabtagene autoleucel-associated movement and neurocognitive toxicity
Research Article May 7 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AML
Research Article May 7 2025
ADORE: an open platform study of ruxolitinib in combination with other novel therapies in patients with myelofibrosis
Letter May 7 2025
Dysregulated immune proteins in plasma in the UK Biobank predict Multiple Myeloma 12 years before clinical diagnosis
Research Article May 2 2025
Eltrombopag in combination with immunosuppressive therapy in pediatric severe aplastic anemia: Phase 2 ESCALATE trial
Research Article May 2 2025
Impact of shared HLA determinants between patient and losing cord blood unit on relapse after double cord blood transplantation
Research Article May 2 2025
Outcomes in Frail Patients Receiving BCMA-directed Bispecific Antibodies for Relapsed/Refractory Multiple Myeloma
Reply May 2 2025
Clarifying the Role of p.Gln723Lys in hTTP Prevalence
Research Article May 2 2025
NTRK1-rearranged histiocytosis: clinicopathologic and molecular features
Research Article May 1 2025
Use of the Microfluidic Impedance Red Cell Assay (MIRCA) in Sickle Cell Disease
Research Article May 1 2025
TRANSCAR: Real-World outcomes of CD19CAR T Cell Therapy in relapsed/refractory transformed indolent lymphomas
Letter May 1 2025
Interpretation of Response in BOS-the Definitions Remain Key
Letter May 1 2025
Targeting Siglec-Sialic Acid Checkpoint to Reverse Immune Dysfunction Mediated by Plasmacytoid Dendritic Cells in Myeloma
Letter May 1 2025
Brentuximab Vedotin and Nivolumab for Untreated Patients with Hodgkin Lymphoma: Long-term Results
Research Article May 1 2025
Belumosudil reduces oral chronic graft-versus-host disease tissue inflammation and fibrosis: a ROCKstar companion study
Research Article April 30 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703
Research Article April 30 2025
Lisocabtagene maraleucel for R/R LBCL in patients not intended for HSCT: final results of the phase 2 PILOT study
Research Article April 30 2025
Real-world effectiveness of immunoglobulin replacement for hypogammaglobulinemia and infections in multiple myeloma
Research Article April 30 2025
Predictive Value of Free Light Chain Burden in Patients with AL Amyloidosis Treated with Bortezomib-Based Regimens
Research Article April 30 2025
Lymphoma B cells remodel bone marrow stromal cells into extracellular matrix-producing cancer-associated fibroblasts
Letter April 29 2025
High rate of complete responses induced by platinum-based regimen with BTK inhibitors in Richter's Syndrome
Page 1 of 3

or Create an Account

Close Modal
Close Modal

Advertisement intended for health care professionals